Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-03

FDA Approved: HAIR REGROWTH TREATMENT — Supplemental Application (CVS Pharmacy)

View source ↗

Summary

The FDA approved a supplemental application for a minoxidil-based hair regrowth product developed by CVS Pharmacy, updating its regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HAIR REGROWTH TREATMENT (MINOXIDIL)

Snippet

SUPPL AP for HAIR REGROWTH TREATMENT (MINOXIDIL)